Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Campo

Showing results (271-280 of 348) with videos related to

Pageof 35
Sort By:
International Journal of Microcirculation, Clinical and Experimental|March 1, 1995
Soluble E-selectin levels in acute human myocardial infarctionF Squadrito, D Altavilla, M Ioculano, et al.
British Journal of Pharmacology|August 28, 1998
Inhibition of tumour necrosis factor and reversal of endotoxin-induced shock by U-83836E, a 'second generation' lazaroid in ratsD Altavilla, F Squadrito, M Serrano, et al.
Anales De Medicina Interna (Madrid, Spain : 1984)|February 1, 1989
[Agranulocytosis caused by captopril: report of a case]F J Ochoa Gómez, C Andrés Nilsson, J Salcedo Aguilar, et al.
Journal of Cardiovascular Pharmacology|January 1, 1992
Protective effects of G 619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, in splanchnic artery occlusion shockF Squadrito, D Altavilla, B Zingarelli, et al.
Meat Science|November 9, 2011
Effects of fatty acids on meat quality: a reviewJ D Wood, R I Richardson, G R Nute, et al.
Neuropharmacology|January 1, 1994
Food deprivation increases brain nitric oxide synthase and depresses brain serotonin levels in ratsF Squadrito, G Calapai, D Altavilla, et al.
Agents and Actions|July 1, 1993
Reduction of myocardial leukocyte accumulation and myocardial infarct size following administration of BAY u3405, a thromboxane A2 receptor antagonist, in myocardial ischaemia-reperfusion injuryF Squadrito, M Ioculano, D Altavilla, et al.
Pharmacology|September 1, 1993
G619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, reduces myocardial damage and polymorphonuclear leukocyte accumulation following coronary artery occlusion and reperfusion in ratsF Squadrito, M Ioculano, D Altavilla, et al.
Agents and Actions|October 1, 1994
TCV-309, a novel platelet activating factor antagonist, inhibits leukocyte accumulation and protects against splanchnic artery occlusion shockP Canale, F Squadrito, D Altavilla, et al.
Pharmacology|March 1, 1994
Protective effects of IRFI-016, a new antioxidant agent, in myocardial damage, following coronary artery occlusion and reperfusion in the ratG M Campo, F Squadrito, M Ioculano, et al.
Pageof 35

Showing results (271-280 of 348) with videos related to

Sort By:
Pageof 35
International Journal of Microcirculation, Clinical and Experimental|March 1, 1995
Soluble E-selectin levels in acute human myocardial infarctionF Squadrito, D Altavilla, M Ioculano, et al.
British Journal of Pharmacology|August 28, 1998
Inhibition of tumour necrosis factor and reversal of endotoxin-induced shock by U-83836E, a 'second generation' lazaroid in ratsD Altavilla, F Squadrito, M Serrano, et al.
Anales De Medicina Interna (Madrid, Spain : 1984)|February 1, 1989
[Agranulocytosis caused by captopril: report of a case]F J Ochoa Gómez, C Andrés Nilsson, J Salcedo Aguilar, et al.
Journal of Cardiovascular Pharmacology|January 1, 1992
Protective effects of G 619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, in splanchnic artery occlusion shockF Squadrito, D Altavilla, B Zingarelli, et al.
Meat Science|November 9, 2011
Effects of fatty acids on meat quality: a reviewJ D Wood, R I Richardson, G R Nute, et al.
Neuropharmacology|January 1, 1994
Food deprivation increases brain nitric oxide synthase and depresses brain serotonin levels in ratsF Squadrito, G Calapai, D Altavilla, et al.
Agents and Actions|July 1, 1993
Reduction of myocardial leukocyte accumulation and myocardial infarct size following administration of BAY u3405, a thromboxane A2 receptor antagonist, in myocardial ischaemia-reperfusion injuryF Squadrito, M Ioculano, D Altavilla, et al.
Pharmacology|September 1, 1993
G619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, reduces myocardial damage and polymorphonuclear leukocyte accumulation following coronary artery occlusion and reperfusion in ratsF Squadrito, M Ioculano, D Altavilla, et al.
Agents and Actions|October 1, 1994
TCV-309, a novel platelet activating factor antagonist, inhibits leukocyte accumulation and protects against splanchnic artery occlusion shockP Canale, F Squadrito, D Altavilla, et al.
Pharmacology|March 1, 1994
Protective effects of IRFI-016, a new antioxidant agent, in myocardial damage, following coronary artery occlusion and reperfusion in the ratG M Campo, F Squadrito, M Ioculano, et al.
Pageof 35